Immunodiagnostic Systems Announcements

Disposal Update

14 November 2008 07:01:54



RNS Number : 1661I Immunodiagnostic Systems Hldgs PLC 14 November 2008  
?
Immunodiagnostic Systems Holdings plc

Immunodiagnostic Systems Holdings plc ("IDS") and Escalon Medical Corporation ("EMC"), the NASDAQ quoted healthcare Company, draw closer to conclusion of the acquisition of IDS' Biocode Hycel haematology division.

EMC and IDS today announce their collaboration on a plan to transfer IDS' Biocode Hycel haematology division to EMC or its subsidiary Drew Scientific Inc.

Discussions are at an advanced stage for the 100% divestment of this division by IDS.

The deal will be finalised assuming successful consultation with the competent employee representative bodies, as required by French Law, and after the subsequent finalisation and signing of the definitive agreement. This is expected to take place before the end of November at which point a further announcement will be made giving full details of the deal terms.

For further information:

Immunodiagnostic Systems Holdings plc                                                        Tel: 0191 519 0660
Roger Duggan, Managing Director  
Paul Hailes, Finance Director

Oriel Securities Limited (Nominated Adviser and Broker)                               Tel: 020 7710 7600
Andrew Edwards
Gareth Price
James Nevin  
 
Parkgreen Communications Limited                                                              Tel: 020 7933 8787
Paul McManus                                                                                          Mob: 07980 541 893
                 paul.mcmanus@parkgreenmedia.com

This information is provided by RNSThe company news service from the London Stock Exchange  END  DISQZLBFVFBEFBV

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.